RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Net income margin (%)

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 202421.8+2.10%
Dec 31, 202321.3+16.55%
Dec 31, 202218.3+26.66%
Dec 31, 202114.5+3505.67%
Dec 31, 20200.4-97.36%
Dec 31, 201915.2-879.63%
Dec 31, 2018-1.9-203.75%
Dec 31, 20171.9-54.53%
Dec 31, 20164.1-472.50%
Dec 31, 2015-1.1-78.20%
Dec 31, 2014-5.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)